The pharmaceutical drug Injectafer (generic name: ferric carboxymaltose), an iron carbohydrate complex used to treat iron deficiency anemia, has been linked to severe hypophosphatemia (HPP) – a dangerously low level of phosphorus in the blood that can cause life-threatening complications….<BR />By: <a href="https://www.jdsupra.com/profile/Robins_Kaplan/">Robins Kaplan LLP</a>
SOURCE: Personal Injury & Products Liability RSS Feed | JD Supra Law News – Read entire story here.